3M7W image
Entry Detail
PDB ID:
3M7W
Keywords:
Title:
Crystal Structure of Type I 3-Dehydroquinate Dehydratase (aroD) from Salmonella typhimurium LT2 in Covalent Complex with Dehydroquinate
Biological Source:
PDB Version:
Deposition Date:
2010-03-17
Release Date:
2010-04-07
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:3-dehydroquinate dehydratase
Chain IDs:A, B, C, D, E, F
Chain Length:255
Number of Molecules:6
Biological Source:Salmonella enterica subsp. enterica serovar Typhimurium
Primary Citation
Insights into the mechanism of type I dehydroquinate dehydratases from structures of reaction intermediates.
J.Biol.Chem. 286 3531 3539 (2011)
PMID: 21087925 DOI: 10.1074/jbc.M110.192831

Abstact

The biosynthetic shikimate pathway consists of seven enzymes that catalyze sequential reactions to generate chorismate, a critical branch point in the synthesis of the aromatic amino acids. The third enzyme in the pathway, dehydroquinate dehydratase (DHQD), catalyzes the dehydration of 3-dehydroquinate to 3-dehydroshikimate. We present three crystal structures of the type I DHQD from the intestinal pathogens Clostridium difficile and Salmonella enterica. Structures of the enzyme with substrate and covalent pre- and post-dehydration reaction intermediates provide snapshots of successive steps along the type I DHQD-catalyzed reaction coordinate. These structures reveal that the position of the substrate within the active site does not appreciably change upon Schiff base formation. The intermediate state structures reveal a reaction state-dependent behavior of His-143 in which the residue adopts a conformation proximal to the site of catalytic dehydration only when the leaving group is present. We speculate that His-143 is likely to assume differing catalytic roles in each of its observed conformations. One conformation of His-143 positions the residue for the formation/hydrolysis of the covalent Schiff base intermediates, whereas the other conformation positions the residue for a role in the catalytic dehydration event. The fact that the shikimate pathway is absent from humans makes the enzymes of the pathway potential targets for the development of non-toxic antimicrobials. The structures and mechanistic insight presented here may inform the design of type I DHQD enzyme inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures